Tag Archives: dutasteride

5-alpha reductase inhibitor slows progression of low-risk prostate cancer tumors

Active surveillance added to treatment with the 5-alpha reductase inhibitor dutasteride slowed the progression of cancerous prostate tumors in men with low-risk localized disease, according to researchers from the University of Toronto in Ontario, Canada. Key Point: Active surveillance in combination with dutasteride is a reasonable strategy for the treatment… 

Read more »
Posted in Oncology, Pharmacology, Urology | Also tagged , , , , | Volume: | Leave a comment